Binding analysis of HLA-G specific antibodies to hematopoietic cells isolated from leukemia patients

Neoplasma

Volumn 50, Issue 5, 2003, Pages 331-338

  Polakova K ^a   Bandzuchova E ^b   Hofmeister, V ^c   Weiss, E H ^c   Hutter, H ^d   Russ, G ^e  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF GRAZ   (Austria)

^e INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

Flow cytometry; HLA G antigen; Human leukemia cells; Immunoblotting; RT PCR

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA G ANTIGEN; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CELL ISOLATION; CHILD; CONTROLLED STUDY; CROSS REACTION; DISSOCIATION; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LEUKEMIA; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; PROTEIN BINDING; PROTEIN EXPRESSION;

EID: 0242322724     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. AMIOT L, ONNO M, DRENOU B, MONVOISIN C, FAUCHET R. HLA-G class I gene expression in normal and malignant hematopoietic cells. Hum Immunol 1998; 59: 524-528.
2. BAINBRIDGE D, ELLIS S, LE BOUTEILLER P, SARGENT I. HLA-G remains a mystery. Trends Immunol 2001; 22: 548-552.
3. BLASCHITZ A, LENFANT F, MALLET V, HARTMANN M, BENSUSSAN A, GERAGHTY DE, LE BOUTEILLER P, DOHR G. Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur J Immunol 1997; 27: 3380-3388.
4. BROUWER RE, VAN DER HEIDEN P, SCHREUDER GMT, MULDER A, DATEMA G, ANHOLT JDH, WlLLEMZE R, CLAAS FHJ, FALKENBURG JHF. Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon. Hum Immunol 2002; 63: 200-210.
5. CABESTRE FA, LEFEBVRE S, MOREAU P, ROUAS-FRIESS N, DAUSSET J, CAROSELLA ED, PAUL P. HLA-G expression: immune privilege for tumour cells? Semin Cancer Biol 1999; 9: 27-36.
6. DAVIES B, HIBY S, GARDNER L, LOKE YW, KING A. HLA-G expression by tumors. Am J Reprod Immunol 2001; 45: 103-107.
7. FRUMENTO G, FRANCHELLO S, PALMISANO GL, NICOTRA MR, GIACOMINI P, LOKE YW, GERAGHTY DE, MAIO M, MANZO C, NATALI PG, FERRARA GB. Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gamma IFN treatment. Tissue Antigens 2000; 56: 30-37.
8. MIZUNO S, EMI N, KASAI M, ISHITANI A, SARRO H. Aberrant expression of HLA-G antigen in interferon gamma-stimulated acute myelogenous leukaemia. Br J Haematol 2000; 111: 280-282.
9. O'CALLAGHAN CA, BELL JI. Structure and function of the human class Ib molecules HLA-E, HLA-F and HLA-G. Immunol Rev 1998; 163: 129-138.
10. PANGAULT C, AMIOT L, CALTI-MAUGENDRE S, BRASSEUR F, GUILLOUX V, DRENOU B, FAUCHET R, ONNO M. HLA-G protein expression is not induced during malignant transformation. Tissue Antigens 1999; 53: 335-346.
11. PAUL P, CABESTRE FA, LEGAL FA, KHALIL-DAHER I, LEDANFF C, SCHMID M, MERCIER S, AVRIL MF, DAUSSET J, GUILLET JG, CAROSELLA ED. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. Cancer Res 1999; 59: 1954-1960.
12. PAUL P, ROUAS-FREISS N, MOREAU P, CABESTRE FA, MENIER C, KHALIL-DAHER L, PANGAULT C, ONNO M, FAUCHET R, MARTINEZ-LASO J, MORALES P, VILLENA AA, GIACOMINI P, NATALI PG, FRUMENTO G, FERRARA GB, McMASTER M, FISHER S, SCHUST D, FERRONE S, DAUSSET J, GERAGHTY D, CAROSELLA ED. HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. Hum Immunol 2000; 61: 1177-1195.
13. POLÁKOVÁ K, KARPÁTOVÁ M, RUSS G. Dissociation of β2-microglobulin is responsible for selective reduction of HLA class I antigenicity following acid treatment of cells. Mol Immunol 1993; 30: 1223-1230.
14. POLÁKOVÁ K, KŔČOVÁ M, KUBA D, RUSS G. Analysis of HLA-G expression in malignant hematopoietic cells from leukemia patients. Leuk Res 2003. In press.
15. POLÁKOVÁ K, BENNINK JR, YEWDELL JW, BYSTRICKÁ M, BAND-ŽUCHOVÁ E, RUSS G. Mild acid treatment induces cross-reactivity of 4H84 monoclonal antibody specific to nonclassical HLA-G antigen with classical HLA class I molecules. Hum Immunol 2003; 64: 256-264.
16. POLÁKOVÁ K, RUSS G. Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted. Neoplasma 2000; 47: 342-348.
17. REAL LM, CABRERA T, CANTON J, OLIVA R, RUIZ-CABELLO F, GARRIDO F. Looking for HLA-G expression in human tumors. J Reprod Immunol 1999; 43: 263-373.
18. REAL LM, CABRERA T, COLLADO A, JIMENEZ P, GARZIA A, RUIZ-CABELLO F, GARRIDO F. Expression of HLA-G in tumors is not a frequent event. Int J Cancer 1999; 81: 512-518.
19. UROSEVIC M, KURRER MO, KAMARASHEV J, MUELLER B, WEDER W, BURG G, STAHEL RA, DUMMER R, TROJAN A. Human leukocyte antigen G up-regulation in lung cancer associates with high grade histology, human leukocyte antigen class I loss and interleukin-10 production. Amer J Pathol 2001; 159: 817-824.
20. UROSEVIC M, WILLERS J, MUELLER B, KEMPF W, BURG G, DUMMER R. HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 2002; 99: 609-617.
21. WAGNER SN, REBMANN V, WILLERS CP, GROSSE-WILDE H, GOOS M. Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma. Lancet 2000; 356: 220-221.